Essential technologies help keep this website secure and working. With your permission, we use optional analytics to understand what works and improve the website. You can browse and enquire without accepting optional cookies, and change your choices at any time. See our Cookie & Similar Technologies Notice.
NHS & HealthTech Assurance
NHS DTAC Readiness & Assurance
Senior support for digital health manufacturers selling health IT systems to NHS organisations and social care. A DTAC gap analysis shows what is missing. We then help you complete a current DTAC form an NHS buyer can test, backed by real evidence across all five DTAC areas, not answers written for the form.
Preparation support and internal readiness review for one product before NHS buyer scrutiny. Internal review is not independent assurance; the manufacturer owns its documentation and the NHS buyer carries out the DTAC assessment.
DTAC answers exist but supporting evidence is thin
03
There is no named Clinical Safety Officer or clinical safety case
04
A DPIA has not been completed for the product
05
Security testing evidence is out of date
06
Your DTAC form predates the refreshed April 2026 version
The service
What DTAC is — and what it is not
The Digital Technology Assessment Criteria (DTAC) are an NHS England assessment framework that care commissioners and providers use when assuring digital health technology products. DTAC covers five areas: clinical safety, data protection, technical security, interoperability, and usability and accessibility. Manufacturers keep an up-to-date DTAC form and supporting documents for each product version and provide them on request; the buyer carries out the assessment. A refreshed form, with fewer questions and less duplication with the DSPT and the medical-device pre-acquisition questionnaire, replaced the previous version from 6 April 2026. DTAC applies alongside, not instead of, other requirements such as medical-device certification or ICO registration.
Preparing an overseas digital health product for NHS buyer review
Start with the product version, intended use, deployment context and the evidence the NHS buyer requests. We review gaps across the five DTAC areas within the agreed scope. Being established overseas does not mean every UK requirement applies: confirm your role and the product’s applicable obligations before preparing evidence.
DTAC preparation is not NHS approval, medical-device certification or a guarantee of procurement. Clinical safety consultancy, a named CSO appointment and DSPT support are separately scoped where required; the manufacturer retains its documentation and the NHS buyer carries out the assessment.
Where clinical risk management evidence needs development beyond the DTAC assessment scope, explore DCB0129 clinical safety consultancy. This work is separately scoped; the manufacturer retains its answers and the NHS buyer carries out the DTAC assessment.
What changes for your organisation
Outcomes the service is built to deliver
Clinical safety
Readiness of your DCB0129 clinical risk management evidence, hazard log and Clinical Safety Officer arrangements behind the clinical-safety answers.
Data protection
DPIA, lawful basis, transparency, DPO arrangements and data-flow evidence for the product as deployed.
Technical security
Review of the technical-security evidence your answers rely on, including a valid Cyber Essentials certificate, any NHS Cyber Security Charter declaration, product-specific security testing where the form requires it, and your DSPT position, with gaps prioritised.
Interoperability
Clarity on the standards, APIs and integration evidence the product relies on, and how they are documented.
Usability and accessibility
A check that usability and accessibility answers are evidenced rather than asserted.
Readiness challenge
A senior practitioner checks completeness, consistency and traceability before buyer scrutiny. This internal readiness review is not independent assurance.
Where are you now?
How the evidence journey can progress
The stages show how readiness work can progress. Your engagement starts and ends at the agreed boundary; not every stage is included.
1
Current state
We confirm the product, version and intended use in scope and baseline what DTAC evidence already exists.
2
Evidence gaps
Existing answers are tested against the evidence behind them, area by area.
3
Remediation
Gaps are closed in priority order against the buyer deadline.
4
Readiness
The DTAC form is brought together with current evidence for each answer.
5
Readiness challenge
A senior practitioner checks completeness, consistency and traceability before buyer scrutiny. This internal readiness review is not independent assurance.
Preparation support helps identify gaps and organise supporting evidence; the manufacturer retains its DTAC answers, decisions and sign-off.
An internal readiness review checks completeness, consistency and traceability within the agreed engagement and is not independent assurance.
Any independent assurance is commissioned separately, subject to competence, objectivity and conflict-of-interest safeguards, and never covers work IG-Smart prepared, managed or delivered. It is performed by practitioners who did not prepare, manage or deliver the work being assessed.
The NHS buyer retains responsibility for its DTAC assessment. Outputs at each stage are examples, not an entitlement at the starting fee.
Every engagement follows IG-Smart’s structured delivery approach: Assess → Build → Manage → Assure → Improve. Explore how we work
What each stage produces
01
Current state
Agreed scope and evidence inventory.
02
Evidence gaps
Evidence gap register with buyer impact and named owners.
03
Remediation
Prioritised remediation plan and updated evidence.
04
Readiness
Buyer-ready DTAC form and evidence map.
05
Readiness challenge
Readiness challenge log with resolutions.
Choose your entry option
Three separate ways to engage
DTAC Gap & Readiness Assessment
Establish the agreed product, version and assessment boundary.
Examine available evidence against applicable DTAC requirements.
Identify material gaps and recommended next steps; reporting outputs are agreed in the proposal.
DTAC Readiness & Remediation Support
Help address agreed documentation, governance and evidence gaps.
Agree client ownership, specialist responsibilities and the extent of support.
A detailed remediation roadmap and remediation delivery are separately scoped where required.
DTAC Pre-Submission Readiness Challenge
A senior practitioner checks completeness, consistency and traceability before buyer scrutiny. This internal readiness review is not independent assurance.
Recommendations before NHS buyer submission; the buyer carries out the DTAC assessment.
IG-Smart does not present its own preparation or remediation work as independently assured. Any separately commissioned independent assurance engagement is subject to appropriate competence, objectivity and conflict-of-interest safeguards.
These are separate engagement options, not mandatory stages included in one fee. You do not need to commission assessment or remediation before a suitable pre-submission challenge. Scope, deliverables, timing and fees are agreed for the selected requirement; the manufacturer retains its answers, decisions and sign-off.
What you receive
The working records this service produces
Illustrative working records across the available engagement options. Formal outputs are agreed in the proposal; these examples are not all included in every starting assessment.
DTAC Readiness Dashboard · Pre-buyer reviewIllustrative data — not client data
Overall positionAmber — closing gaps
DTAC areas evidenced
3 / 5
▲ 1 this period
Open evidence gaps
6
▼ 3 vs last review
Responses challenged
18
▲ 12 resolved
Evidence owners assigned
9 / 10
▲ 2 this period
Evidence gaps by buyer impact
High1
Medium3
Low2
Evidence complete
68%
Overdue actions
2
Documents awaiting sign-off
3
Matters for escalation
1
Illustrative output
DTAC Readiness Dashboard
Readiness at a glance
A single view of readiness across the five DTAC areas, so gaps are closed before an NHS buyer reviews the form.
What it helps you see
Readiness across the five DTAC areas
Open evidence gaps by buyer impact
Readiness challenge progress
Evidence owners and sign-off status
Likely format
Dashboard / reporting view · Supporting registers and evidence records · Executive PDF summary where agreed
DTAC evidence mapIllustrative data — not client data
Illustrative DTAC evidence map
Area
Evidence held
Status
Owner
Area A
Draft document, not approved
Partly evidenced
Product lead
Area B
Assessment completed
Evidenced
Privacy lead
Area C
Test report out of date
Gap
Engineering lead
Illustrative output
DTAC evidence map
Evidence coverage
Each core area linked to the evidence that supports it.
What it helps you see
Each DTAC core area
Supporting evidence
Coverage gaps
Evidence owner
Likely format
Evidence gap registerIllustrative data — not client data
Illustrative Evidence gap register
Gap
Buyer impact
Effort
Target
Gap A
High
Medium
Before buyer review
Gap B
Medium
Low
Before buyer review
Gap C
Low
High
Next release
Illustrative output
Evidence gap register
Gaps by buyer impact
Gaps sequenced by buyer impact and effort.
What it helps you see
Each evidence gap
Buyer impact
Effort to close
Sequence and owner
Likely format
Cross-framework overlap viewIllustrative data — not client data
Illustrative Cross-framework overlap view
Evidence item
DTAC
DSPT
Clinical safety
Evidence item A
Yes
Yes
—
Evidence item B
Yes
—
Yes
Evidence item C
Yes
Yes
Yes
Illustrative output
Cross-framework overlap view
Reuse of evidence
Where one piece of evidence supports several requirements.
What it helps you see
Evidence supporting several requirements
Frameworks it maps to
Duplication avoided
Remaining gaps
Likely format
Readiness challenge logIllustrative data — not client data
Illustrative Readiness challenge log
Response
Challenge raised
Resolution
Status
Response A
Claim broader than evidence
Wording narrowed
Closed
Response B
Evidence not dated
Current version added
Closed
Response C
Owner unclear
Owner assigned
Open
Illustrative output
Readiness challenge log
Response testing
Every response tested against its evidence.
What it helps you see
Each DTAC response
Evidence it relies on
Challenge raised
Status before buyer review
Likely format
Illustrative structure — not a client document. Exact outputs and formats depend on the agreed scope.
Scope boundaries
Assessment scope and separately commissioned support
DTAC concerns the product; DSPT concerns organisational assurance. Neither replaces the applicable clinical safety obligations. Review of evidence does not automatically include specialist testing or clinical programme delivery.
Starting assessment — proposal-defined
Agree product, version and assessment boundary
Review available evidence against applicable requirements across the five DTAC areas
Identify material gaps and recommended next steps
Agree assessment depth, client inputs and reporting outputs in the proposal
Separately scoped where required
Formal Clinical Safety Officer appointment
Full DCB0129 or DCB0160 clinical safety programme delivery
Penetration testing and code or infrastructure remediation
Standalone specialist accessibility testing
Interoperability or integration build work
Detailed remediation roadmap, remediation delivery and ongoing managed information governance
Scope, deliverables and assumptions are agreed in writing before work begins.
Relevant evidence
Related NHS & HealthTech evidence
Selected published engagements demonstrating relevant governance, privacy, assurance and NHS/HealthTech capability. They are not presented as DTAC engagements unless the underlying approved case evidence expressly states that.
Named client · Technology / SaaS / RegTech
Clini-Hub
Embedded governance and clinical-safety support since start-up
NHS AI Toolkit, DSPT, DTAC and clinical-safety governance from start-up
“Partnering with IG-Smart Ltd has been one of the most transformative decisions we have made as an organisation. Their team’s depth of expertise and unwavering dedication has enabled Clini-Hub to achieve and maintain full compliance with all NHS standards applicable to us, including the AI Toolkit, DSPT, DTAC, and DCB standards.”
Specialist expertise, coordinated around your requirement
Subject-matter expertise is paired with a clear client and programme contact from initial scoping through delivery.
Subject-matter expert
Michael Abtar
LLB (Hons), PG.Dip.Law, Cert. DPO
IG-Smart’s senior consultants, including Michael Abtar, bring collective experience of governance work involving more than 100 million consumer records.
Following defined-scope DTAC readiness work, separately scoped HealthTech governance can support evidence maintenance, remediation, change-triggered reviews, assurance coordination and appropriate senior practitioner input. The manufacturer retains its documentation, decisions and sign-off; the NHS buyer carries out the DTAC assessment.
Further services are optional and separately scoped. Assessment, remediation, implementation and managed support are distinct from independent assurance; independent assurance cannot cover work for which IG-Smart held delivery or management responsibility.
NHS England describes DTAC as an assessment framework used by care commissioners and providers. The buyer carries out the assessment using the manufacturer’s current DTAC form and supporting documents.
Do you complete the DTAC form for us?
No. The form and its answers remain the manufacturer’s, and the NHS buyer carries out the assessment. We help you assess, evidence and challenge your answers so each one can be substantiated.
What changed in the refreshed DTAC?
NHS England published a refreshed form and guidance in early 2026, with fewer questions, less duplication with the DSPT and pre-acquisition questionnaire, and a focus on software-based digital health technologies. The previous form was retired from 6 April 2026. Reviews of some underlying standards, including DCB0129 and DCB0160, are continuing.
How does DTAC relate to DSPT and DCB0129?
DTAC assesses a specific product. The DSPT is organisational assurance used alongside it. DCB0129 (manufacturers) and DCB0160 (deploying organisations) are the clinical risk management standards behind clinical safety. We map where one piece of evidence supports several requirements, so work is not duplicated.
Can you act as our Clinical Safety Officer?
Clinical Safety Officer support is scoped separately. DTAC readiness focuses on whether your clinical-safety evidence will stand up to buyer review.
What if the product changes after the form is shared?
Manufacturers are expected to keep the DTAC form current for each product version. We agree review triggers — new functionality, integrations, AI or deployment context — so your answers stay accurate.
How long does DTAC readiness preparation take?
Delivery depends on product maturity, version stability, available evidence, the extent of identified gaps and the availability of relevant stakeholders. During scoping, we agree the proposed timetable, client responsibilities and milestones, taking account of any procurement or submission deadline. Urgent requirements are assessed against available capacity before an engagement is confirmed.
Indicative investment: £7,500–£10,000 + VAT, depending on scope and existing evidence.
This range concerns readiness assessment work, not a fixed bundled price for all three engagement options. The final investment, deliverables, assumptions and responsibilities are agreed in writing before work begins.
Delivery timing is agreed during scoping, taking account of scope, evidence maturity, dependencies and the procurement deadline.
What does the starting DTAC assessment cover?
IG-Smart agrees the product and version in scope, reviews available evidence against the applicable DTAC requirements and identifies material gaps and recommended next steps. Assessment depth, stakeholder participation, reporting outputs and any subsequent remediation support are confirmed in the engagement proposal.
Review across the five DTAC areas is not exhaustive specialist testing of every control, system or document. Specialist technical testing, formal clinical safety appointments and remediation delivery are separately scoped where required.
Working towards an NHS procurement deadline?
Tell us your target date and what evidence is already available. We can assess the feasibility of an appropriate readiness engagement before agreeing the scope.